Joining Forces with Google to Revolutionize Breast Cancer Screening Worldwide
by Dana Brown, President and CEO of iCAD, Inc. We’ve joined forces with Google Health once again to address two of the most pressing challenges in healthcare: the global radiologist shortage and significant disparities in healthcare. Per our 20-year worldwide agreement, Google’s AI technology will seamlessly integrate into our ProFound...
What is CAD?
Computer-Aided Detection (CAD) is a sophisticated FDA-approved technology that helps radiologists identify characteristics that may be associated with various forms of cancer. By using iCAD patented algorithms to mark suspicious areas, CAD serves as a “second pair of eyes” and acts very much like a “spell checker” to identify characteristics...
Why RCI Became the First in the State to Adopt ProFound AI as its Breast AI Solution for Mammography
Iowa’s largest radiology group, Radiology Consultants of Iowa (RCI), offers a wide range of imaging services for patients, including breast cancer screening. In addition to the mammograms done at their imaging center, which is accredited by the American College of Radiology (ACR) as a Breast Imaging Center of Excellence, RCI...
Why ProFound AI Prevailed as the Premier AI Solution in a Competitive Trial at Wake Radiology
With 14 imaging locations in the Raleigh-Durham metropolitan area, also known as “the Triangle,” Wake Radiology offers a wide array of imaging exams in the outpatient setting, including both screening and diagnostic mammography. Renowned for state-of-the-art care, in August 2013 Wake Radiology began to upgrade to 3D mammography, or DBT,...
Why Kettering Health Traded out Previous AI Software for ProFound AI® Enterprise-Wide
The Story of Kettering Health A leading faith based, not-for-profit hospital system in southwest Ohio, Kettering Health has been providing quality patient care and cancer screening at its world-class cancer centers for 48 years. The team at Kettering takes great pride in ensuring that its facilities are equipped with the...
ImageCare Centers Unveils PINK Better Mammo Service, Featuring Profound AI®, the World’s First FDA Cleared Artificial Intelligence Solution for 3D Mammography
ImageCare Centers recently announced it will adopt ProFound AI® for Digital Breast Tomosynthesis (DBT) throughout all of ImageCare’s mammography centers this October as part of its “PINK Better Mammo” service. ProFound AI® was the first artificial intelligence (AI) software for DBT, or 3D mammography, to be FDA cleared; the software...
Rabin Medical Center Evaluates iCAD’s ProFound AI to Improve Accuracy and Efficiency
Rabin Medical Center (RMC), one of the most prominent and largest medical facilities in Israel, recently initiated a clinical evaluation involving ProFound AI® for Digital Breast Tomosynthesis (DBT) at the Radiology Department at the Clalit Rabin Medical Center. Owned and operated by Clalit Health Services, RMC is Israel’s largest health...
Dense Breasts: What You Should Know
Author: JoAnn Pushkin Breast Cancer Awareness Month is here and a good time to educate women on an important aspect in the detection of breast cancer: breast density. The purpose of breast cancer screening is to detect cancer earlier than it would otherwise be found. When breast cancer is found...
Navicent Health Adopts Profound AI for Digital Breast Tomosynthesis
Clinically Proven Technology Enhances Breast Cancer Detection, Improves Accuracy Navicent Health recently announced that they have added the latest development in the fight against breast cancer – iCAD’s Profound AI for digital breast tomosyntheses (DBT), also known as 3D mammography – to their Mammography Program. ProFound AI for DBT was...
Ten Factors to Consider When Selecting an AI Vendor for Breast Imaging
Manually reviewing breast images for small abnormalities in a deluge of hundreds of mammographic images can mean long days for radiologists, which can lead to reader fatigue and increase the potential for missed cancers. False positives from older 2D computer-aided detection (CAD) technologies result in unnecessary biopsies, which are not...